ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Micro Labs Limited. The primary component is Aspirin; Dipyridamole.
| Product ID | 42571-274_c96e6a99-7604-c2e5-e053-2a95a90a44a2 |
| NDC | 42571-274 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE |
| Generic Name | Aspirin And Extended-release Dipyridamole |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-08-16 |
| Marketing Category | ANDA / |
| Application Number | ANDA209929 |
| Labeler Name | Micro Labs Limited |
| Substance Name | ASPIRIN; DIPYRIDAMOLE |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| Pharm Classes | Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-08-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42291-116 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |
| 42571-274 | ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE | ASPIRIN and Extended-Release DIPYRIDAMOLE |
| 51407-271 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |
| 60687-305 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |
| 62175-330 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |
| 62559-850 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |
| 65162-596 | Aspirin and Extended-Release Dipyridamole | Aspirin and Extended-Release Dipyridamole |